Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial
| KDHIX Fund | USD 61.37 0.50 0.82% |
Slightly above 51% of Deutsche Croci's investor base is interested to short. The analysis of overall sentiment of trading Deutsche Croci Equity mutual fund suggests that many investors are impartial at this time. Deutsche Croci's investing sentiment can be driven by a variety of factors including economic data, Deutsche Croci's earnings reports, geopolitical events, and overall market trends.
Deutsche |
Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for the treatment of prostate cancer and other cancers, today announced the receipt of the first shipments of non-carrier added Actinium 225 from Cardinal Health.
Read at finance.yahoo.com
 |
Deutsche Croci Fundamental Analysis
We analyze Deutsche Croci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Croci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Croci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Deutsche Croci is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Deutsche Croci Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Croci mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Croci could also be used in its relative valuation, which is a method of valuing Deutsche Croci by comparing valuation metrics with similar companies.
Peers
Deutsche Croci Related Equities
| KTRAX | Deutsche Global | 0.20 | ||||
| SRMAX | Deutsche Short-term | 0.10 | ||||
| KTRCX | Deutsche Global | 0.1 | ||||
| KTCAX | Deutsche Science | 0.02 | ||||
| SRMCX | Deutsche Short | 0.00 | ||||
| SRMSX | Deutsche Short | 0.00 | ||||
| KTCIX | Deutsche Science | 0.04 | ||||
| KTCSX | Deutsche Science | 0.05 | ||||
| KTCCX | Deutsche Science | 0.06 | ||||
| GCGGX | Deutsche Gnma | 0.17 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Croci financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Croci security.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |